Medarde A, del Hierro J, Aramburu E, Esquíroz P, Martínez J L
Banco de Sangre, Navarra.
Rev Med Univ Navarra. 1988 Oct-Dec;32(4):209-16.
The following is a review of the data of hepatitis-B serology study obtained during the last sixteen years in the Blood Bank of Navarra. The prevalence of HBsAg carriers is 0.87% (204 positive cases in 23,409 blood donors studied). The methods used during this period have been: AGD (7 positive donors, i.e. 3.4%), CIEP (4 positive donors, i.e. 1.9%), HARP (78 positive donors, i.e. 38.2%), EIA (93 positive donors, i.e. 45.5%) and RIA (22 positive donors, i.e. 10.7%). The number of previous donations before the detection of HBsAg dropped from 7/8 in the first group of donors to 4/5 in the second and to 1 in the third group. A deeper study has been carried out in 120 of those blood donors, including the detection of anti-HBs, anti-HBc, HBeAg and anti-HBe. A low-infectivity pattern has been found in 92 (76.6%), high infectivity in 4 (3.3%) and seroconversion in 16 (13.3%). It hasn't been possible to interpret the pattern of the remaining 8 (6.6%). Both the sensitivity and the specificity of our actual screening method have been found adequate in a cooperative study carried out in a group of Blood Banks in Spain in 1985.
以下是对纳瓦拉血库过去16年乙肝血清学研究数据的回顾。乙肝表面抗原(HBsAg)携带者的患病率为0.87%(在23409名接受检测的献血者中有204例阳性)。在此期间使用的检测方法有:琼脂扩散试验(AGD,7例阳性献血者,即3.4%)、对流免疫电泳(CIEP,4例阳性献血者,即1.9%)、高效液相放射免疫沉淀法(HARP,78例阳性献血者,即38.2%)、酶免疫分析法(EIA,93例阳性献血者,即45.5%)和放射免疫分析法(RIA,22例阳性献血者,即10.7%)。在检测出HBsAg之前的既往献血次数,从第一组献血者中的7/8降至第二组的4/5,再降至第三组的1次。对其中120名献血者进行了更深入的研究,包括检测乙肝表面抗体(抗-HBs)、乙肝核心抗体(抗-HBc)、乙肝e抗原(HBeAg)和乙肝e抗体(抗-HBe)。发现92例(76.6%)为低感染模式,4例(3.3%)为高感染模式,16例(13.3%)为血清学转换。其余8例(6.6%)的模式无法解读。在1985年西班牙一组血库开展的合作研究中,发现我们现行筛查方法的敏感性和特异性均足够。